Updates and role of cytogenetics in ewings family of tumors, few lines for ewings family of tumor Pathogenesis morphology also 10 marks md pathology exam
"Ewing sarcoma" AND cytogenetics
Ewing sarcoma histology small round blue cells

Alveolar rhabdomyosarcoma (ARMS) histology image demonstrating malignant soft tissue tumor composed of irregular aggregates of poorly differentiated round to oval cells. Tumor nests are separated by thick, hyalinized fibrous septa containing dilated capillaries and small vessels. Central cells within nests retain intercellular cohesion, resulting in partial or immature alveolar-like architecture rather than a fully formed alveolar pattern. The high nuclear-to-cytoplasmic ratio, hyperchromatic round to oval nuclei, and scant cytoplasm characterize these small round blue cells. Occasional mitotic figures and necrotic debris may be evident in aggressive neoplasms. Immunophenotypically, ARMS typically shows positivity for myogenin and MyoD1, desmin, and other skeletal muscle differentiation markers; cytogenetics often reveals PAX3-FOXO1 or PAX7-FOXO1 translocations. Clinically this histology correlates with high-grade, aggressive pediatric/adolescent soft tissue sarcoma with a propensity for metastasis. Differential considerations include embryonal rhabdomyosarcoma (ERMS), Ewing sarcoma/undifferentiated round cell sarcoma, synovial sarcoma, and nonrhabdomyoblastic small round blue cell tumors. The image highlights diagnostic features relevant to surgical pathology, oncology, and pathology education. This morphological snapshot supports diagnostic pathology workflows, guiding immunohistochemistry panels and molecular testing. Relevance spans medical education, case review, and research on rhabdomyosarcoma subtypes and alveolar architecture. Clinical utility includes guiding targeted IHC panels, FISH/MET testing, and treatment planning for patients.

This histopathology image shows a high-grade osseous neoplasm with features suggestive of small cell osteosarcoma. The tissue is an H&E stained bone biopsy observed under light microscopy in a sagittal section of a long bone origin. The cellular population comprises small to medium-sized round to oval cells with scant cytoplasm, hyperchromatic nuclei, and prominent nucleoli; marked cellularity with focal nuclear pleomorphism. A distinctive lace-like, delicate osteoid matrix is interwoven between malignant cells, often forming lacey, trabecular strands that identify osteogenic differentiation despite a predominant small cell morphology. Osteoid is essential for distinguishing osteosarcoma from mimicking small round blue cell tumors such as Ewing sarcoma. Immunophenotype characteristic: SATB2 positive; CD99 negative; other markers may help exclude lymphoma or rhabdomyosarcoma. Molecular testing can show absence of EWSR1 and FUS rearrangements. The image may display mitoses and occasional necrosis, consistent with high-grade sarcoma. Diagnostic significance lies in differentiating from Ewing sarcoma due to treatment implications: Ewing is highly radiosensitive and often treated with radiotherapy, while small cell osteosarcoma typically requires surgical resection combined with neoadjuvant chemotherapy. Prognosis is poorer than conventional osteosarcoma. This histology is crucial for guiding multidisciplinary management, prognostication, and therapeutic planning. Correlative studies include immunohistochemistry and molecular profiling for confirmation.

Imaging modality: Light microscopy (Histology) of bone tumor tissue. Specimen: scapular bone biopsy from a 72-year-old male. Staining: Hematoxylin and Eosin (H&E). The histologic section shows high cellularity of small round blue cells with scant cytoplasm and hyperchromatic nuclei arranged in sheets infiltrating and replacing osteolytic trabeculae. The tumor disrupts normal lamellar bone with extensive marrow invasion and focal necrosis; mitotic activity is evident. Immunophenotype usually shows diffuse CD99 membranous positivity; molecular confirmation often reveals EWSR1 gene rearrangement (e.g., EWS-FLI1), supporting Ewing sarcoma. Clinically, this lesion represents an aggressive malignant small round blue cell tumor of bone with metastatic potential; radiographic correlation commonly demonstrates moth-eaten, lytic lesions. Although Ewing sarcoma typically affects children and adolescents, this case illustrates scapular involvement in an older adult. Differential diagnoses include lymphoma, osteosarcoma with small cell features, rhabdomyosarcoma, and metastatic neuroblastoma/PNET. The image is valuable for education, radiology-pathology correlation, and differential diagnosis training in musculoskeletal oncology. Potential clinical use includes diagnostic reference, teaching file inclusion, and research into Ewing family tumors and their atypical age distribution. This microscopic image contextually complements radiographs showing bone destruction and helps in teaching differential patterns among small round blue cell tumors in the pediatric and adult skeleton.

This histopathology image pair presents a bone-tumor specimen stained with PAS (left) and PAS-D (right) to highlight intracytoplasmic glycogen in Ewing sarcoma cells. The left panel shows strong magenta cytoplasmic staining within sheets of small round blue cells, consistent with PAS-positive glycogen-rich cytoplasm. The right panel demonstrates diastase digestion (PAS-D) where glycogen is hydrolyzed, and the cytoplasm adopts a pale pink to near unstained appearance, confirming glycogen as the source of PAS positivity. The tumor cells exhibit uniform, small cell morphology with high nuclear-to-cytoplasmic ratio, round to oval nuclei, delicate chromatin, and scant cytoplasm; occasional rosette-like arrangements may be observed. The two-panel comparison emphasizes the diagnostic utility of PAS-PAS-D staining in differentiating glycogen-rich Ewing sarcoma cells from other small round blue cell tumors. Pathologically, this glycogen-rich cytoplasm is a hallmark feature that supports EWSR1-related neoplasms; diastase sensitivity is key to ruling in glycogen as the substrate. Clinically, these findings are relevant for pathology workflows, differential diagnosis, and educational purposes, and they guide ancillary studies, including immunohistochemistry for CD99, NKX2.2, and molecular testing for EWSR1 rearrangements. This image is valuable for prognostic and therapeutic decision-making in pediatric and young adult bone oncology research and diagnostics, and for histology teaching in pathology curricula.
Ewing sarcoma family tumors WHO classification 2024 update molecular EWSR1 FLI1 fusion cytogenetics FISH

| Fusion | Frequency | Genes |
|---|---|---|
| t(11;22)(q24;q12) | ~85-90% | EWSR1-FLI1 |
| t(21;22)(q22;q12) | ~5-10% | EWSR1-ERG |
| Rare variants | <5% | EWSR1-ETV1, EWSR1-ETV4, EWSR1-FEV, FUS-ERG |